Journal article

Weight-related safety outcomes of lisdexamfetamine dimesylate in children and adolescents with ADHD: Post-hoc analysis from a phase 3, randomized, double-blind, multicentre, parallel-group, placebo- and active-controlled, dose-optimized study in Europe

A Zuddas, DR Coghill, T Banaschewski, C Soutullo, A Lynes, P Hodgkins, M Gasior

Neuropsychiatrie de l'Enfance et de l'Adolescence | Elsevier BV | Published : 2012